Following the merger Aventis has increasingly focused on its pharmaceutical activitities. Other parts of the business have been sold off. Of particular importance was the sale of Aventis Crop Sciences to Bayer in 2002.
Recital 27, Decision_act (EU) 2004/104
In forcesince 27 Nov 2002